Medications & Complications

Medications

CELLCEPT® (mycophenolate mofetil)

Purpose:
Fights rejection by decreasing the number of white blood cells the immune system produces.

How to take:

  • Capsules - 250 mg blue and brown; Tablets - 500 mg lavender.
  • CellCept should be taken twice a day on an empty stomach.

Precautions:
Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of renal or cardiac transplant patients should use CellCept. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.

Principal Side effects:
These include, but are not limited to, diarrhea, leukopenia (a decrease in the number of white blood cells which can increase the chance of infection), sepsis (a condition associated with a bacterial infection of the blood), vomiting and an increased susceptibility to certain types of infections and lymphoma. Patients receiving CellCept should be monitored for neutropenia. Immediately report to your doctor any evidence of infection (for example, fever, chills, sore throat, cough, unexplained bruising or bleeding).



<Back      Return to: Medications

Home Page  |  Glossary  |  Site Map
University of Southern California USC Liver Transplant Program and Center for Liver Disease
1510 San Pablo Street, Suite 200, Los Angeles CA 90033-4612
Phone: (323) 442-5908     Fax: (323) 442-5721
E-mail: uscliver@surgery.hsc.usc.edu